Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure VI: Adjunct Therapies

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

Cardiac Catheterization IV: Nursing Management

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Diagnostic Approach to Left Ventricular Hypertrophy: A Review.

US cardiology·2026

Same author

Impact of Mavacamten on Disease-Related Symptoms in Patients With Obstructive Hypertrophic Cardiomyopathy: HCMSQ Outcomes in EXPLORER-HCM.

Journal of cardiac failure·2026

Same author

The Role of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock-Part 1: Pathophysiology and Current Evidence.

Interventional cardiology clinics·2026

Same author

The Role of Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock-Part Two: Getting with the Guidelines and the Future ahead.

Interventional cardiology clinics·2026

Same author

Long-Term Impact of Frailty on Outcomes Following Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy.

JACC. Advances·2026

Same author

Impact of "Door-to-Lactate Clearance" on Clinical Outcomes in Cardiogenic Shock.

JACC. Heart failure·2026

Search research articles

Related Experiment Video

Updated: Mar 1, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Hemodynamic Support Devices for Complex Percutaneous Coronary Intervention.

Basil Alkhatib¹, Laura Wolfe¹, Srihari S Naidu²

¹Division of Cardiology, Winthrop University Hospital, 120 Mineola Boulevard, Suite 500, Mineola NY 11501, USA.

Interventional Cardiology Clinics

|June 6, 2017

Summary

This summary is machine-generated.

High-risk percutaneous coronary intervention (PCI) uses hemodynamic support devices for complex cases. Guidelines recommend these devices to improve outcomes for high-risk patients undergoing PCI.

Keywords:

Complex coronary intervention High risk PCI Support devices Ventricular assist devices

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

Related Experiment Videos

Last Updated: Mar 1, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

Area of Science:

Interventional Cardiology
Cardiovascular Medicine

Background:

High-risk percutaneous coronary intervention (PCI) is increasing.
These patients have complex clinical and anatomic factors.
They face high complication risks but may benefit most from complete revascularization.

Purpose of the Study:

Discuss patient populations benefiting from hemodynamic support during high-risk PCI.
Review available hemodynamic support devices and strategies.
Outline expected outcomes for this patient group.

Main Methods:

Review of trial data.
Analysis of consensus documents.
Evaluation of current guidelines.

Main Results:

Hemodynamic support is recommended for high-risk PCI.
Specific patient groups derive significant benefit.
Various devices and strategies are available.

Conclusions:

Hemodynamic support is crucial for selected high-risk PCI patients.
Choosing the right device and strategy impacts outcomes.
Further research may refine optimal use.